The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The pharmaceutical firm Novo Nordisk is pursuing a multipronged strategy to regain market share that it has lost to Eli Lilly ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

A decision is expected in the fourth quarter of 2025.

The $560 million company will stop selling products at Woolworths and Priceline and concentrate on selling weight-loss drugs ...